What’s the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.
Aging starts in our cells, and those aging cells can hasten cellular senescence, leading to tissue dysfunction and related health impacts.
New research involving University of Minnesota Medical School faculty Paul D. Robbins and Laura J. Niedernhofer, recently published in Nature Medicine, shows there are types of small molecules called senolytics that can reverse the impact of aged, senescent cells.
“We’ve always thought of aging as a process, not a disease,” said Dr. Robbins, Associate Director of the newly founded Institute on the Biology of Aging and Metabolism (iBAM). “But what if we can influence the impacts of aging at a cellular level to promote healthy aging? That’s what senolytics seeks to achieve.”
The research determined whether introducing senescent cells to human and animal tissue would impact the cellular health of surrounding cells. Surprisingly, the transplant of a relatively small number of senescent cells caused persistent physical dysfunction as well as the spread of cellular senescence in previously healthy cells.
In addition, researchers found that a high fat diet, which causes a type of metabolic stress, or simply being old, enhances the physical dysfunction that comes from senescent cells.
“Previous research has shown that our immune system’s ability to eliminate or deal with senescent cells is based 30 percent on genetics and 70 percent on environment,” said Dr. Robbins, noting that what we eat and how often we exercise can affect senescence or aging of cells.
Conversely, the researchers determined that treatment with senolytic drugs, able to eliminate senescent cells, can reverse physical dysfunction and actually extend lifespan even when used in aged animal models.
“We saw greater activity, more endurance, and greater strength following use of senolytics,” said Dr. Robbins.
The paper notes that the results provide proof-of-concept evidence that improved health and lifespan in animals is possible by targeting senescent cells. The hope is that senolytics will prove effective in alleviating physical dysfunction and resulting loss of independence in older adult humans as well.
“This area of research is promising, not just to address the physical decline that comes with aging, but also to enhance the health of cancer survivors treated with radiation or chemotherapy – two treatments that can induce cell senescence,” said Laura Niedernhofer, Director of iBAM.
The Latest on: Senolytic drugs
via Google News
The Latest on: Senolytic drugs
- U of M researchers awarded $19.3 million in NIH grants to map senescent cellson September 16, 2022 at 8:53 am
Researchers at the University of Minnesota Medical School and the Institute on the Biology of Aging and Metabolism were awarded a total of $19.3 million in grants from the National Institutes of ...
- Idiopathic Pulmonary Fibrosison August 31, 2022 at 5:00 pm
Anurag Verma of ... Mayo Clinic researchers say senolytic drugs can boost a key protein in the body that protects older people against aspects of aging and a range of diseases. Their findings ...
- Global Longevity And Anti-Senescence Therapy Market Assessment Worth $ 41.10 Billion By 2030 - By Insightace Analyticon August 19, 2022 at 10:50 am
Ltd. announces the release of a market assessment report on the 'Global Longevity and Anti-Senescence Therapy Market - by Therapy (Senolytic Drug Therapy, Gene Therapy, Cell Therapy, Mitochondrial ...
- Qualia Senolytic, Breakthrough Product That Promotes Senescent Cell Elimination, Sells Out In Weekson August 16, 2022 at 6:38 am
Senolytic ingredients appear to support the ... These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent ...
- Longevity And Anti-Senescence Therapy Market To Rise With Spectacular Growth By 2030on August 8, 2022 at 1:07 pm
PORTLAND, OREGON, UNITED STATES, August 8, 2022 /EINPresswire.com / -- Allied Market Research published a report, titled, 'Longevity and Anti-senescence Therapy Market by Therapy (Senolytic Drug ...
- Cocktail of two Senolytic drugs can Mitigate Disc Degeneration, Finds a New Researchon September 8, 2021 at 6:48 am
Intervertebral disc degeneration is one of the most common diseases among the elderly population. The disease occurs due to the breakdown (degeneration) of one or more of the discs, the spongy ...
via Bing News